Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
90Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $107.88M | $-33.52M | $-0.67 |
| 2024 | $90.05M | $-38.07M | $-0.78 |
| 2023 | $70.19M | $-43.10M | $-1.66 |
| 2022 | $37.05M | $-44.04M | $-2.78 |
| 2021 | $22.24M | $-29.00M | $-2.38 |
Social Signal Score
Valuation
MXDHFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (3)
- Newsbenzinga.com·1d ago·Positive
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' MDxHealth SA (NASDAQ:MDXH) stock skyrocketed on Friday after the diagnostic company reported mixed quarterly earnings.
View source ↗ - Newsseekingalpha.com·1d ago·Positive
MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·1d ago·Neutral
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates MDxHealth SA (MDXH) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.15 per share a year ago.
View source ↗